stock price decline

BRBR faces securities fraud lawsuit alleging misrepresented sales growth. Investors must file claims by March 23, 2026.

CoreWeave faces securities fraud lawsuit alleging false statements about operational capabilities and undisclosed data center project delays. Class action deadline: March 13, 2026.

Rosen Law Firm investigates PennyMac Financial for alleged disclosure issues after Q4 earnings triggered 33% stock decline on January 30, 2026.

Robbins Geller sues Richtech Robotics for misrepresenting Microsoft partnership scope. Stock fell 29% after Microsoft clarified relationship was limited to AI lab, not commercial deal.

Vistagen's failed drug trial caused 81% stock drop. Securities lawsuit filed for investors who bought shares April 2024-December 2025. Lead plaintiff deadline: March 16, 2026.

Bath and Body Works faces securities lawsuit alleging false statements about business strategy. Stock dropped 24.8% after missing Q3 guidance with declining revenue and net income.

Inovio Pharmaceuticals faces securities lawsuit over false statements about manufacturing and regulatory prospects. FDA rejected accelerated approval for lead drug candidate, causing 24% stock drop.

Law firm investigates Ramaco Resources for alleged securities fraud over inactive Wyoming mine despite reported groundbreaking. Class action deadline: March 31, 2026.

Law firm investigates Ralliant for potential securities violations after $1.4B goodwill impairment announcement causes 31.8% stock decline, questioning disclosure timing and accuracy.

Robbins LLP files class action against Paysafe Limited for alleged misrepresentations about client risk and financial guidance. Stock fell 27.6% in November 2025.

Law firm seeks lead plaintiffs for class actions against Ramaco Resources and Beyond Meat over alleged misrepresentations. Deadlines are March 31 and March 24, 2026.

Law firm Kaskela LLC investigates BARK Inc. over 60% stock decline, examining whether leadership violated securities laws or breached fiduciary duties to shareholders.

Law firm investigates Danone for securities fraud over contaminated infant formula from Thailand. Stock fell nearly 11% following disclosure of toxic bacterial contamination in formula batches.